IMATINIB MESYLATE IN THE TREATMENT OF PAEDIATRIC CHRONIC MYELOID LEUKEMIA: A STUDY OF 55 PATIENTS FROM A TERTIARY CARE CANCER CENTRE IN PAKISTAN

被引：0
|
作者：
Rashid, Aqeela [1 ]
Maaz, Ata [2 ]
机构：
[1] Shaukat Khanum Hosp, Lahore, Pakistan
[2] Bristol Royal Hosp Children, Bristol, Avon, England
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1038 / 1038
页数：1
相关论文
共 50 条
  • [21] IMATINIB MESYLATE INDUCED HEPATOTOXICITY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML)
    Milosevic, V.
    Bogdanovic, A.
    Djordjevic, V.
    Fekete, M. Dencic
    Mihaljevic, B.
    Gotic, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 545 - 546
  • [22] Administration of imatinib mesylate in patients with chronic myeloid leukemia with short bowel
    Yamazaki, Rie
    Aisa, Yoshinobu
    Mori, Takehiko
    Iketani, Osamu
    Ikeda, Yasuo
    Okamoto, Shinichiro
    LEUKEMIA & LYMPHOMA, 2009, 50 (04) : 670 - 672
  • [23] Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate
    Arora, B
    Kumar, L
    Sharma, A
    Wadhwa, J
    Kochupillai, V
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 358 - 359
  • [24] Cytogenetic responses in chronic myeloid leukemia patients treated with imatinib mesylate
    Babameto-Laku, A.
    Mokin, V.
    Cikuli, M.
    Xhumari, P.
    CHROMOSOME RESEARCH, 2005, 13 : 158 - 158
  • [25] Imatinib mesylate, a new drug for chronic myeloid leukemia in pediatric patients
    Thavaraj, Vasantha
    Seth, Rachna
    WORLD JOURNAL OF PEDIATRICS, 2007, 3 (02) : 110 - 114
  • [26] Nutritional Status of Patients with Chronic Myeloid Leukemia Treated with Imatinib Mesylate
    Jose Castillo-Martinez, Maria
    Juventina Tuna-Aguilar, Elena
    del Pilar Milke-Garcia, Maria
    Camacho Zamora, Anais
    Villegas Cervantes, Viviana
    Castillo-Martinez, Lilia
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (09): : 3211 - 3216
  • [27] IMATINIB MESYLATE IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) PATIENTS
    Ionita, H.
    Ionita, I.
    Cheveresan, M.
    Iordache, M.
    Cheveresan, L.
    Ionita, M.
    Borzak, G.
    Ionita, C. O.
    Pascalau, A.
    Calamar, D.
    Oros, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 548 - 548
  • [28] FIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE
    Eskazan, A. E.
    Baslar, Z.
    Ayer, M.
    Kantarcioglu, B.
    Arica, D.
    Demirel, N.
    Aydin, D.
    Yalniz, F. F.
    Elverdi, T.
    Salihoglu, A.
    Ar, M. C.
    Aydin, S. Ongoren
    Aydin, Y.
    Tuzuner, N.
    Ozbek, U.
    Soysal, T.
    HAEMATOLOGICA, 2014, 99 : 330 - 331
  • [29] Efficacy of the expanded treatment program with imatinib mesylate in 109 patients with chronic myeloid leukemia (CML)
    Vysotskaya, L.
    Golenkov, A.
    Trifonova, E.
    Chernykh, Y.
    Lutskaya, T.
    Inyutkina, N.
    Chukavina, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 532 - 532
  • [30] Predictors of Treatment Non-Adherence in Patients Treated with Imatinib Mesylate for Chronic Myeloid Leukemia
    StCharles, Meaghan
    Bollu, Vamsi K.
    Hornyak, Elizabeth
    Coombs, John
    Blanchette, Christopher M.
    DeAngelo, Daniel J.
    BLOOD, 2009, 114 (22) : 870 - 870
12345